SCHEMBL14754891

SCHEMBL14754891

CCc1cncc(-c2ncco2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGDS O60760 1/20 0.39
▸ BACE1 P56817 4/20 0.37
▸ CHRNA7 P36544 1/20 0.37
▸ CHRNA10 Q9GZZ6 1/20 0.37
▸ CHRNA9 Q9UGM1 1/20 0.37
▸ CCNC P24863 2/20 0.36
▸ CDK8 P49336 2/20 0.36
▸ GLRA3 O75311 1/20 0.36
▸ GLRB P48167 1/20 0.36
▸ ADORA2A P29274 1/20 0.36
▸ GPR55 Q9Y2T6 2/20 0.35
▸ LTA4H P09960 1/20 0.35
▸ CYP11B2 P19099 1/20 0.34
▸ BACE2 Q9Y5Z0 2/20 0.34
▸ PRMT5 O14744 1/20 0.33
▸ WDR77 Q9BQA1 1/20 0.33
▸ NOS3 P29474 1/20 0.33
▸ NOS1 P29475 1/20 0.33
▸ NOS2 P35228 1/20 0.33
▸ CCNK O75909 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13354410 0.77 HPGDS (0.42) HPGDSBACE1CHRNA7CHRNA10CHRNA9
SCHEMBL12648428 0.77 NOTUM (0.50) HPGDSCHRNA7CHRNA10CHRNA9GLRA3
SCHEMBL8239613 0.75 LTA4H (0.50) HPGDSCHRNA7CHRNA10CHRNA9LTA4H
SCHEMBL13466616 0.74 HPGDS (0.42) HPGDSBACE1CCNCCDK8GLRA3
SCHEMBL19156716 0.73 HPGDS (0.39) HPGDSBACE1CHRNA7CHRNA10CHRNA9
SCHEMBL14752258 0.73 HPGDS (0.39) HPGDSBACE1CHRNA7CHRNA10CHRNA9
SCHEMBL13086678 0.73 HPGDS (0.39) HPGDSBACE1CHRNA7CHRNA10CHRNA9
Hydrochloric Acid SCHEMBL30555492 0.72 HPGDS (0.41) HPGDSBACE1CCNCCDK8GLRA3
SCHEMBL13177775 0.72 CYP1A1 (0.45) BACE1GPR55CYP11B2PRMT5WDR77
SCHEMBL13737200 0.70 HPGDS (0.53) HPGDSBACE1CHRNA7CHRNA10CHRNA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130059835-A1 HETEROCYCLYLAMINES AS PI3K INHIBITORS INCYTE CORPORATION (US) 2013-03-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130059835-A1 HETEROCYCLYLAMINES AS PI3K INHIBITORS PIK3CA, PIK3CD, PIK3CB HPGDS 228/4885BACE1 2873/4885CHRNA7 3619/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback